Join Us at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) 2025
We’re excited to invite you to join us at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) 2025, the leading event for professionals dedicated to advancing cancer immunotherapy. This year’s event will be held from November 5th – 9th, 2025, at the Gaylord National Resort and Convention Center, National Harbor, MD. SITC 2025 is an essential gathering for immunotherapy researchers, clinicians, and industry experts looking to connect, share insights, and explore the future of cancer treatment.
About SITC 2025
SITC 2025 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. SITC 2025 also includes updates on major national and international initiatives from academia, government and industry, as well as important society projects.
The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.
Event Location
Location: Gaylord National Resort and Convention Center, National Harbor, MD
Date: November 5th – 9th 2025
Agenda: Link to Conference Program
Key Speakers and Information
SITC 2025 will host a lineup of distinguished speakers from leading institutions and organizations, covering critical topics in cancer immunotherapy, including:
- Novel Immune Checkpoint Inhibitors
- CAR-T Cell Therapy Advancements
- Emerging Biomarkers for Immunotherapy
- Innovations in Personalized Cancer Vaccines
For a complete list of speakers and the full agenda, visit the conference program.
Who Will Be There?
SITC 2025 attracts a diverse group of attendees, including:
- Oncology Researchers and Clinicians – Leading scientists and practitioners dedicated to advancing cancer immunotherapy.
- Pharmaceutical and Biotech Executives – Professionals from top companies interested in the latest immunotherapy trends and clinical applications.
- Clinical Development Teams – Experts focused on integrating immunotherapy advancements into clinical practice.
- Academic Institutions and Research Centers – Representatives from top universities and research institutes showcasing pioneering work.
This event provides unmatched networking opportunities and a platform to explore the latest in cancer immunotherapy with thought leaders and innovators from across the globe. Don’t miss this chance to be part of the conversation shaping the future of immunotherapy.